ABOUT US

---

FDA-Partners provides integrated regulatory, clinical, quality, and project management strategy across the product development lifecycle. We specialize in developing regulatory, clinical, GxP, and market access strategies, enabling successful FDA pre-market submissions, site inspections, and approvals across diverse therapeutic areas, including medical devices, SaMD/Digital Health, IVDs, and combination products.

With senior-level experts and a pragmatic, least-burdensome mindset, we align regulatory strategy, clinical evidence, and quality considerations into a single, executable plan and stay engaged through FDA interactions, submissions, and inspection readiness.

For international biopharma companies entering the U.S., we provide targeted pathway and study design expertise to enable rapid progress and durable success. These engagements center on U.S. regulatory and clinical pathway strategy, study design, RWD/RWE framing, and GCP/GMP readiness, helping global innovators bridge regional development practices with FDA expectations. 

Designed as an expert advisory firm, FDA-Partners functions as an extension of your organization—engaged, decisive, and fully committed to achieving optimal results from the start.

Founded by FDA senior leadership, our mission is to help innovators navigate FDA complexity with confidence: translating regulatory uncertainty into clear strategy and high-quality execution that stands up to review. As an expert advisory firm, we provide personalized regulatory, clinical, quality, and project management strategies across the product development lifecycle with proactive client engagement.